Our finding about cholestasis-induced vascular hyporeactivity mediated by alternation in MaxiK and KATP expression may shed new light on the mechanism of cardiovascular dysfunction in cholestasis and may help identify new therapeutic targets in this setting. The gene discussed is KCNMA1; the disease is cholestasis.